Targeted Self-Help for Quitting Smoking in Cancer Patients
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new self-help program designed to motivate cancer patients to quit smoking. It targets those recently diagnosed with certain cancers, such as breast, colorectal, gynecological, skin melanoma, or bladder cancer. Participants will receive either the usual care or the usual care plus this targeted self-help intervention (a print-based self-help program) to determine its effectiveness in helping them quit smoking. Those who have smoked at least one cigarette in the past month and are not currently in a smoking cessation program might be suitable candidates. As an unphased trial, this study offers a unique opportunity to contribute to research that could enhance smoking cessation support for cancer patients.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this self-help intervention is safe for cancer patients?
Research has shown that printed self-help materials can assist people trying to quit smoking, especially those without other support. These materials help more people stop smoking compared to doing nothing at all.
In this study, the self-help materials are unique because they are personalized for cancer patients who smoke, aiming to boost their motivation to quit. No reports of negative effects have emerged from using these materials, as they are educational rather than a physical treatment or medication.
Thus, this method is generally safe. It focuses on providing information and motivation, which is unlikely to cause harm.12345Why are researchers excited about this trial?
Researchers are excited about the Targeted Self-Help intervention for quitting smoking in cancer patients because it offers a personalized approach, unlike the standard nicotine replacement therapies or prescription medications. This method is customized to each patient's needs, potentially increasing motivation and adherence compared to generic programs. Additionally, by integrating psychological support in a self-directed format, it empowers patients to take control of their quitting journey, which could lead to improved outcomes and a higher success rate in quitting smoking.
What evidence suggests that the Targeted Self-Help intervention is effective for quitting smoking in cancer patients?
Research shows that self-help materials can aid smoking cessation, especially when other support is unavailable. Evidence indicates that printed self-help materials are more effective than no intervention in helping people quit smoking. This trial will compare the effectiveness of usual care alone with usual care plus the Targeted Self-Help Intervention. Self-help tools, such as workbooks and online programs, can enhance quality of life and reduce stress for cancer patients. While this study focuses on cancer patients, earlier research found that these materials can also motivate smoking cessation in this group.12367
Who Is on the Research Team?
Ursula Martinez, PhD
Principal Investigator
Huntsman Cancer Institute
Are You a Good Fit for This Trial?
This trial is for individuals over 18 who smoke and have been diagnosed with breast, colorectal, gynecological, skin melanoma, or bladder cancer within the last 6 months. Participants must be able to read/write English and give informed consent. Men with breast cancer or those already in a smoking cessation program cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a brief self-help intervention targeted by cancer type to increase motivation to quit smoking
Follow-up
Participants are monitored for adherence, retention, and acceptability of the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Targeted Self-Help
Targeted Self-Help is already approved in United States, European Union for the following indications:
- Smoking cessation
- Smoking cessation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Utah
Lead Sponsor
National Cancer Institute (NCI)
Collaborator